Successful awarded therapeutic modality for rare and difficult pathology of leucoderma has been developed by DRDO and transferred to M/s AIMIL Pharmaceuticals (India) Ltd, New Delhi. The medicine is successful pan India with nearly One Lakh registered patients being treated currently